132 related articles for article (PubMed ID: 16185885)
1. Synthesis of chromenochalcones and evaluation of their in vitro antileishmanial activity.
Narender T; Khaliq T; Shweta ; Nishi ; Goyal N; Gupta S
Bioorg Med Chem; 2005 Dec; 13(23):6543-50. PubMed ID: 16185885
[TBL] [Abstract][Full Text] [Related]
2. Arylanthranilodinitriles: a new biaryl class of antileishmanial agents.
Singh FV; Vatsyayan R; Roy U; Goel A
Bioorg Med Chem Lett; 2006 May; 16(10):2734-7. PubMed ID: 16503140
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro antileishmanial activity of 5-substituted-2'-deoxyuridine derivatives.
Peyron C; Benhida R; Bories C; Loiseau PM
Bioorg Chem; 2005 Dec; 33(6):439-47. PubMed ID: 16168460
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of oxysterols and nitrogenous sterols with antileishmanial and trypanocidal activities.
Bazin MA; Loiseau PM; Bories C; Letourneux Y; Rault S; El Kihel L
Eur J Med Chem; 2006 Oct; 41(10):1109-16. PubMed ID: 16949702
[TBL] [Abstract][Full Text] [Related]
5. Dihydropyrido[2,3-d]pyrimidines as a new class of antileishmanial agents.
Agarwal A; Ramesh ; Ashutosh ; Goyal N; Chauhan PM; Gupta S
Bioorg Med Chem; 2005 Dec; 13(24):6678-84. PubMed ID: 16126395
[TBL] [Abstract][Full Text] [Related]
6. S-Euglobals: biomimetic synthesis, antileishmanial, antimalarial, and antimicrobial activities.
Bharate SB; Khan SI; Tekwani BL; Jacob M; Khan IA; Singh IP
Bioorg Med Chem; 2008 Feb; 16(3):1328-36. PubMed ID: 17976995
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antiprotozoal activity of some new synthetic substituted quinoxalines.
Hui X; Desrivot J; Bories C; Loiseau PM; Franck X; Hocquemiller R; Figadère B
Bioorg Med Chem Lett; 2006 Feb; 16(4):815-20. PubMed ID: 16309903
[TBL] [Abstract][Full Text] [Related]
8. Syntheses of new substituted triazino tetrahydroisoquinolines and beta-carbolines as novel antileishmanial agents.
Kumar A; Katiyar SB; Gupta S; Chauhan PM
Eur J Med Chem; 2006 Jan; 41(1):106-13. PubMed ID: 16356594
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of Triclisia patens and some bisbenzylisoquinoline alkaloids against Leishmania donovani and Trypanosoma brucei brucei.
del Rayo Camacho M; Phillipson JD; Croft SL; Rock P; Marshall SJ; Schiff PL
Phytother Res; 2002 Aug; 16(5):432-6. PubMed ID: 12203262
[TBL] [Abstract][Full Text] [Related]
10. An antileishmanial chalcone from Chinese licorice roots.
Christensen SB; Ming C; Andersen L; Hjørne U; Olsen CE; Cornett C; Theander TG; Kharazmi A
Planta Med; 1994 Apr; 60(2):121-3. PubMed ID: 8202561
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of marine alkaloid: 8,9-dihydrocoscinamide B and its analogues as Novel class of antileishmanial agents.
Gupta L; Talwar A; Nishi ; Palne S; Gupta S; Chauhan PM
Bioorg Med Chem Lett; 2007 Jul; 17(14):4075-9. PubMed ID: 17548194
[TBL] [Abstract][Full Text] [Related]
12. A convenient and biogenetic type synthesis of few naturally occurring chromeno dihydrochalcones and their in vitro antileishmanial activity.
Narender T; Shweta ; Gupta S
Bioorg Med Chem Lett; 2004 Aug; 14(15):3913-6. PubMed ID: 15225696
[TBL] [Abstract][Full Text] [Related]
13. Effect of pyrazoloquinoline derivatives on the growth of Leishmania donovani promastigotes.
Al-Qahtani A; Siddiqui YM; Bekhit AA; El-Sayed OA; Aboul-Enein HY; Al-Ahdalb MN
Arch Pharm (Weinheim); 2005 Oct; 338(10):484-7. PubMed ID: 16211660
[TBL] [Abstract][Full Text] [Related]
14. Structurally diverse 5-substituted pyrimidine nucleosides as inhibitors of Leishmania donovani promastigotes in vitro.
Torrence PF; Fan X; Zhang X; Loiseau PM
Bioorg Med Chem Lett; 2006 Oct; 16(19):5047-51. PubMed ID: 16879965
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo antileishmanial efficacy of a new nitrilquinoline against Leishmania donovani.
Nakayama H; Desrivot J; Bories C; Franck X; Figadère B; Hocquemiller R; Fournet A; Loiseau PM
Biomed Pharmacother; 2007; 61(2-3):186-8. PubMed ID: 17360145
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy of leishmaniasis part III: synthesis and bioevaluation of novel aryl substituted terpenyl pyrimidines as antileishmanial agents.
Chandra N; Pandey S; Ramesh ; Suryawanshi SN; Gupta S
Eur J Med Chem; 2006 Jun; 41(6):779-85. PubMed ID: 16697490
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antileishmanial activity of novel buparvaquone oxime derivatives.
Mäntylä A; Rautio J; Nevalainen T; Vepsälainen J; Juvonen R; Kendrick H; Garnier T; Croft SL; Järvinen T
Bioorg Med Chem; 2004 Jul; 12(13):3497-502. PubMed ID: 15186834
[TBL] [Abstract][Full Text] [Related]
18. Azaterphenyl diamidines as antileishmanial agents.
Hu L; Arafa RK; Ismail MA; Wenzler T; Brun R; Munde M; Wilson WD; Nzimiro S; Samyesudhas S; Werbovetz KA; Boykin DW
Bioorg Med Chem Lett; 2008 Jan; 18(1):247-51. PubMed ID: 18006310
[TBL] [Abstract][Full Text] [Related]
19. Biomimetic synthesis, antimicrobial, antileishmanial and antimalarial activities of euglobals and their analogues.
Bharate SB; Bhutani KK; Khan SI; Tekwani BL; Jacob MR; Khan IA; Singh IP
Bioorg Med Chem; 2006 Mar; 14(6):1750-60. PubMed ID: 16274995
[TBL] [Abstract][Full Text] [Related]
20. Antileishmanial, antiplasmodial and cytotoxic activities of 12,16-dideoxy aegyptinone B from Zhumeria majdae Rech.f. & Wendelbo.
Moein MR; Pawar RS; Khan SI; Tekwani BL; Khan IA
Phytother Res; 2008 Mar; 22(3):283-5. PubMed ID: 17886231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
